Vitiligo
📧 Sign up to get email alerts when something new happens for Vitiligo.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients
A clinical trial sponsored by Assiut University is evaluating serum Gasdermin D as a potential biomarker of disease activity in patients wit…
-
CLINICAL_TRIALS other · 2024-08-09Clinical Trial Update: Gasdermin D Expression in Generalized Vitiligo Patients After Narrow-band Ultraviolet B Therapy [NA]
Clinical trial investigating Gasdermin D expression in generalized vitiligo patients after narrow-band UVB therapy; this study is not yet re…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients [Phase 2]
A Phase 2 study of SYHX1901 Tablet for non-segmental vitiligo is ongoing and currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of ARQ-252 Cream 0.3% for non-segmental facial vitiligo was terminated. The study results…
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: Vitiligo and Psychodrama Therapy [NA]
A completed clinical trial evaluating psychodrama therapy for vitiligo. The trial status is COMPLETED and phase is not applicable.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo [Phase 2]
Phase 2 trial evaluating the efficacy, safety, and tolerability of Crisaborole with and without PF-07038124 and/or NBUVB in Vitiligo has com…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.
This clinical trial evaluates the efficacy and tolerance of the cosmetic product RV5098A for maintaining facial pigmentation in adults with …
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo [NA]
A clinical trial sponsored by Sohag University is evaluating hypoxia-inducible factor and autophagy-related gene expression in patients with…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo [NA]
This clinical trial update shows a study evaluating autologous platelet-rich plasma intradermal injections combined with 308 nm excimer ligh…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo [NA]
This clinical trial update reports completed results for assessing how depigmented skin in vitiligo patients tolerates UVB-targeted photothe…
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy [NA]
A completed clinical trial from Johns Hopkins University investigated early molecular changes in vitiligo following narrowband UV therapy, w…
-
FDA approval · 2024-01-08FDA Approved: METHOXSALEN — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for methoxsalen submitted by Strides Pharma Science Limited. This action updates the approved la…
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: A Study to Evaluate the Mechanism of Action of Ruxolitinib Cream in Subjects With Vitiligo (TRuE-V MOA) [Phase 2]
This phase 2 trial evaluated the mechanism of action of ruxolitinib cream in subjects with vitiligo; the study has completed and results wer…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions [NA]
A clinical study evaluating RECELL for repigmentation of stable vitiligo lesions has completed, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo [Phase 3]
A Phase 3 trial assessing long-term efficacy and safety of topical ruxolitinib cream for vitiligo has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Comparative Study Between Topical 5-fluorouracil and Latanoprost in Vitiligo. [Phase 2, Phase 3]
A comparative Phase 2/Phase 3 trial examines topical 5-fluorouracil versus latanoprost for vitiligo; study completed.
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Evaluation of Effect and Tolerance of the Association of Baricitinib and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo [Phase 2]
A Phase 2 trial assessing the efficacy and tolerance of combining baricitinib with phototherapy versus phototherapy alone in adults with pro…
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Diphenylcyclopropenone (DPCP) as a Depigmenting Therapy in Extensive Vitiligo [Phase 4]
Phase 4 clinical trial assessing Diphenylcyclopropenone (DPCP) as a depigmenting therapy for extensive vitiligo completed.
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: Secukinumab in Active Non-segmental Vitiligo [Phase 4]
Phase 4 clinical trial investigating secukinumab in active non-segmental vitiligo has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face [Phase 2]
Phase 2 clinical trial investigating changes in pigmentation and safety of afamelanotide in patients with vitiligo on the face.
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) [Phase 4]
Phase 4 trial update on vitiligo, focusing on the Koebner phenomenon and immunological analysis.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) [Phase 3]
TRuE-V2, a Phase 3 trial evaluating topical ruxolitinib (Opzelura) for non-segmental vitiligo, completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo [Phase 2, Phase 3]
A phase 2/phase 3 clinical trial evaluating the efficacy and safety of SHR0302 ointment for vitiligo has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo [Phase 4]
Phase 4 clinical trial comparing fractional CO2 laser-assisted cutaneous delivery of methotrexate versus 5-fluorouracil for stable non-segme…
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects [Phase 2]
Phase 2b study evaluating PF-06651600 and PF-06700841 in active non-segmental vitiligo has completed; results posted.